Skip to main content
Top
Published in: International Urology and Nephrology 9/2023

10-05-2023 | Erectile Dysfunction | Urology - Original Paper

Evaluation of knowledge of priapism in sickle cell patients in Senegal

Authors: Oumar Gaye, Moussa Seck, Mourtalla Gueye, Sokhna Aicha Toure, Blaise Felix Faye, Ngor Mack Thiam, Mohamed Jalloh, Madina Ndoye, Lamine Niang, Papa Ahmed Fall, Saliou Diop

Published in: International Urology and Nephrology | Issue 9/2023

Login to get access

Abstract

Purpose

Erectile dysfunction is a dreadful complication of priapism especially with delay in diagnosis and management. The lack of awareness of priapism as a vaso-occlusive complication of sickle cell disease (SCD) is more concerning. The objective of this study was to evaluate the burden of priapism in adult Senegalese males adults with sickle cell disease.

Methods

A cross-sectional study was carried out amongst consecutive consenting males aged 18 years and older with SCD presenting to the in Haematology Department of the National Blood Transfusion Centre (Dakar, Senegal). All participants completed a questionnaire detailing knowledge on the definition of priapism, its association with SCD, consequences of untreated priapism and treatment options.

Results

A total of 219 participants completed the questionnaire. The mean age of the respondents was 27.1 years with a range of (18—54).
Of the respondents, 78.5% (n = 172) did not have any knowledge of the term “priapism”. After the term was explained, 38.4% (n = 84) thought that there may be a risk of developing priapism given the diagnosis of sickle cell disease. Among the participants, 41.5% (n = 91) reported having a history of priapism.
Among all patients who experienced priapism, 36.3% (n = 33) did not seek medical attention with episodes of priapism. It was found that 48.4% (n = 106) of the participants thought there may be a risk of irreversible complications associated with priapism and a corresponding proportion, 42% (n = 92) thought this risk was time dependent. 36.5% (n = 80) of patients believed priapism could lead to erectile dysfunction.

Conclusion

Priapism is a common complication of sickle cell disease in Senegalese adults which is not well known by sickle cell patients. The health authorities must undertake efforts to raise awareness of priapism as a complication amongst sickle cell patients.
Literature
2.
go back to reference Esoh K, Wonkam-Tingang E, Wonkam A (2021) Sickle cell disease in sub-Saharan Africa: transferable strategies for prevention and care. Lancet Haematol 8(10):744–755CrossRef Esoh K, Wonkam-Tingang E, Wonkam A (2021) Sickle cell disease in sub-Saharan Africa: transferable strategies for prevention and care. Lancet Haematol 8(10):744–755CrossRef
3.
go back to reference Bruno D, Wigfall DR, Zimmerman SA et al (2001) Genitourinary complications of sickle cell disease. J Urol 166:803–811CrossRefPubMed Bruno D, Wigfall DR, Zimmerman SA et al (2001) Genitourinary complications of sickle cell disease. J Urol 166:803–811CrossRefPubMed
4.
go back to reference Diagne BA, Ba M, Seye SI et al (1986) Priapisme: problèmes étiologiques et thérapeutiques. Afr Med 25:351–358 Diagne BA, Ba M, Seye SI et al (1986) Priapisme: problèmes étiologiques et thérapeutiques. Afr Med 25:351–358
6.
go back to reference Lin G, Xin ZC, Lue TF et al (2003) Up and down-regulation of phosphodiesterase-5 as related to tachyphylaxis and priapism. J Urol 170:15–18CrossRef Lin G, Xin ZC, Lue TF et al (2003) Up and down-regulation of phosphodiesterase-5 as related to tachyphylaxis and priapism. J Urol 170:15–18CrossRef
9.
go back to reference Adeyoju AB, Olujohungbe ABK, Morris J et al (2002) Priapism in sickle cell disease; incidence, risk factor and complications. An int Multicen Stud BJU Int 90:898–902CrossRef Adeyoju AB, Olujohungbe ABK, Morris J et al (2002) Priapism in sickle cell disease; incidence, risk factor and complications. An int Multicen Stud BJU Int 90:898–902CrossRef
10.
go back to reference Emond AM, Holman R, Hayes RJ et al (1980) Priapism and impotence in homozygous sickle cell disease. Arch Intern Med 140:1434–1437CrossRefPubMed Emond AM, Holman R, Hayes RJ et al (1980) Priapism and impotence in homozygous sickle cell disease. Arch Intern Med 140:1434–1437CrossRefPubMed
11.
go back to reference Anele UA, Burnett AL (2015) Erectile dysfunction after sickle cell disease-associated recurrent ischemic priapism: profile and risk factors. J Sex Med 12(3):713–719CrossRefPubMedPubMedCentral Anele UA, Burnett AL (2015) Erectile dysfunction after sickle cell disease-associated recurrent ischemic priapism: profile and risk factors. J Sex Med 12(3):713–719CrossRefPubMedPubMedCentral
12.
go back to reference Gaye O, Seck M, Gueye SM et al (2022) Évaluation de la sexualité des drépanocytaires adultes homozygotes ayant des antécédents de priapisme au Sénégal. Prog Urol 32(12):862–867CrossRefPubMed Gaye O, Seck M, Gueye SM et al (2022) Évaluation de la sexualité des drépanocytaires adultes homozygotes ayant des antécédents de priapisme au Sénégal. Prog Urol 32(12):862–867CrossRefPubMed
13.
go back to reference Gbadoe AD, Diagne I, Ilboudo A et al (2007) Priapisme chez le drépanocytaire Sénégalais : prévalence, attitudes et connaissances. Bull Soc Pathol Exot 100(3):179–181PubMed Gbadoe AD, Diagne I, Ilboudo A et al (2007) Priapisme chez le drépanocytaire Sénégalais : prévalence, attitudes et connaissances. Bull Soc Pathol Exot 100(3):179–181PubMed
14.
go back to reference Okokoa AR, Odzébé ASW, Moyena E et al (2014) Priapisme chez l’enfant et l’adolescent drépanocytaire homozygote à Brazzaville. Prog urol 24:57–61CrossRef Okokoa AR, Odzébé ASW, Moyena E et al (2014) Priapisme chez l’enfant et l’adolescent drépanocytaire homozygote à Brazzaville. Prog urol 24:57–61CrossRef
15.
go back to reference Gbadoe AD, Dogba A, Segbena AY et al (2001) Priapism in sickle cell anemia in Togo, prevalence and knowledge of this complication. Hemoglobin 25:355–361CrossRefPubMed Gbadoe AD, Dogba A, Segbena AY et al (2001) Priapism in sickle cell anemia in Togo, prevalence and knowledge of this complication. Hemoglobin 25:355–361CrossRefPubMed
16.
go back to reference Wallois A, Vianb E, Lokoc G et al (2012) Évaluation de la sexualité chez les patients afro-caribéens drépanocytaires homozygotes SS suivis en Martinique. Prog urol 22:301–306CrossRefPubMed Wallois A, Vianb E, Lokoc G et al (2012) Évaluation de la sexualité chez les patients afro-caribéens drépanocytaires homozygotes SS suivis en Martinique. Prog urol 22:301–306CrossRefPubMed
17.
go back to reference Carnicelli D, Akakpo W (2018) Le priapisme : diagnostic et prise en charge. Prog urol 28(14):772–776CrossRefPubMed Carnicelli D, Akakpo W (2018) Le priapisme : diagnostic et prise en charge. Prog urol 28(14):772–776CrossRefPubMed
18.
go back to reference Bachir D, Virag R, Lee K et al (1997) Prévention et traitement des troubles érectiles de la drépanocytose. Rev Med Interne 18:46–51CrossRef Bachir D, Virag R, Lee K et al (1997) Prévention et traitement des troubles érectiles de la drépanocytose. Rev Med Interne 18:46–51CrossRef
19.
go back to reference Idris IM, Abba A, Galadanci JA et al (2020) Men with sickle cell disease experience greater sexual dysfunction when compared with men without sickle cell disease. Blood Adv 4(14):3277–3283CrossRefPubMedPubMedCentral Idris IM, Abba A, Galadanci JA et al (2020) Men with sickle cell disease experience greater sexual dysfunction when compared with men without sickle cell disease. Blood Adv 4(14):3277–3283CrossRefPubMedPubMedCentral
20.
Metadata
Title
Evaluation of knowledge of priapism in sickle cell patients in Senegal
Authors
Oumar Gaye
Moussa Seck
Mourtalla Gueye
Sokhna Aicha Toure
Blaise Felix Faye
Ngor Mack Thiam
Mohamed Jalloh
Madina Ndoye
Lamine Niang
Papa Ahmed Fall
Saliou Diop
Publication date
10-05-2023
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 9/2023
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-023-03628-8

Other articles of this Issue 9/2023

International Urology and Nephrology 9/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.